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leaflets (46 vs, 20%, p = 0.C0"~) and moderate or severe mdral regurgitation 
(52 vs, 32%, p = 0,001 ) with :~ut significant age or sex differences, 
Conclusions' TVP in ass¢ clarion with MVP is infrequent, even in a referral 
population, and presents in patients with more severe myxomatous valve 
disease~ 
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~-3~ Enhen~KI Vls,,,sllutlon of Intrnvsscular Thrombus 
~ With t~lS U~!~- O? S Thrombus Targeting UltrHound 
Contrast Agsnt (MRX408): Evldenco From In Vivo 
Exl~r lmental  E,' .hO¢lrdlographk: StudkHI 
M, Takouchi, T,P M¢Creary, E Avetar, M Sheahan, R, Connolly, 
A, Santanen. E Ung~r, N, Pandian, Tufts- New England Medcal Center, 
~ton ,  Mass, USA 
Background: Detection of intr~so~tar thrembu~ (IVT) is not always easy 
by COnventional ul~rase~nd in~tgmg, We explored the potential of a new 
contrast agent t~rgetedto throm~rs (MRX408) using a I@d synthesized with 
a fargetiog mo~ety that is an RG3 analog in the evaluation of in v~o Iv'r. 
Methods: We moated intravascu!ar thrombus (Iv'r) by inserting thrombin 
soaked cotton threads into the infenor vena cava (IVC) in 9 dogs, With a 
Commercially available 2-D ech¢cardiographic System, we recorded images 
of the IVC at baseline w~th no ¢t,ntrast agent, during COntinuous infusion of 
MRXlt3 (a nontargetedcontrast agent as a Control) and intusmn o1 targeted 
agent, MRX408 Videointensity (VI, unitless) and the size of IVT (area) were 
analyzed blindly, Presence 0t IVT was venfied by autopsy. 
Results: In all instances of IVT, eff¢lent binding by the agent MRX408 and 
visually apparent increase in ultrasound contrast enhancement were noted. 
Vl o11VT was not different betwee't baseline and MRX113 (40.0 ± 14.6 and 
73.9 ± 41.3, p = ns) but was hKjher dunng MRX408 infusion (105.7 ± 47.8, p 
< 0.05 vs. Baseline and vs MRX113). The maximum area of IVT was similar 
dunng baseline and MRX 113 (p = ns) but was found to be target dunng 
MRX408 thfusion by >41 ± 9%and >34 ± 14%, (P < 0.01 for each). 
Conclus~n: The tissue targeted contrast agent, MRX408 enhances the 
wsualtzation of IVC thrombus It has the potential to improve the diagnostic 
power for detecting and delineating intravascular thrombus, even when a 
conventional ultrasound imaging medaflty is employed. 
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~ US/International Muit icenter Trial of Atrial Septal 
Catheter Closure Using the Amplatzer Septal 
Occluder: Initial Results 
J. Masura, PE  Lango, J.L Wilkinson, HH Kramer, M. Alwi. Y. Goussous. 
B. Thanopul0s, K.P. Walsh, Z.M HijaZL FOr the Aroplatzer Investigators, 
The Children's University Hospital, Bratislava, Sfovek Republic and 
Tutts-New England Medical Center, Boston, MA, USA 
From 9/95-8/'97, 229 patients with secunduro atrial septal defect, 11 with 
patent foramen ovale and associated stroke and 3 with tenestrated Fortran 
undenNent ranscatheter closure using the new self-centering, repositionable 
Amplatzer" Septal Occluder (ASO) at a median age of 6.6 yr (0.9-70 yr) and 
median weight of 22 kg (6.5-120 kg). The median size 0t the defect by 2D 
TEE was 12 rom (2-23 mm) and the median balloon stretched diameter was 
15 mm (3-26 ram). The median size o1 the device (size of COnnecting waist 
beh,,,een the h'~o disks) used to close the detect was 15 mm (4-26 ram). In lew 
patients, both disks of the device were inadvertently opened either in the left 
or right atrium, because of the ability of repositioning the de~ce, eventually 
all patients had correct device deployment. The median fluoroscopy time 
was 16 min, (2.3-64 rain.) and median total procedure time was 90 rain, 
(27-139 rain.). Complications included were 2 device embolization to the 
RV with successful catheter etrieval and 1 endocarditis necessitating device 
removal and I with transient ischemic attack. At 24 hours by color Doppler, 
74% of patients had complete (C) closure, 15% had trivial residual shunt 
(TS) and 6% had small residual shunt (SS). At one month follow-up by color 
Doppler, 91% of patients had C and 4.6% had TS and 2.8% had SS. No 
episodes of wire fracture or disruption. We conclude that the new ASO is 
safe and effective in completely closing most alrial communications. 
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8~- -~ Simu.l.tan_eoualy Implanted "Cr l socrou lng"  Slants 
PrOVlOe Excel lent Relief for Postoperat ive Bilateral 
Proximal Pulmonary ArIew Stenosmu With Closely 
Related ear ls  
T,M Zeltors, C,E, Mullins, M.R, Nthllt, RG, Gnfka, F,F Ing, gaYlOr College at 
Medicine and Tex~s Chil~en~ Hospital, ~n ,  T~, USA 
Background: For patents with Postoperative pt.t!nlorlary artery =!lenoses, ex- 
pandable intrevascu!ar slant placement is the treatment of choice. However, 
patients with postoperative t:dlatoml proximal pulm0nary artery ~efloses 
(PBPP$), with Closely related branch ost~, present a spec~l problem as 
proximal stent implantation rttRy compromise acces~ to the eontralateral ~d- 
mona~ adery. We hypothesized that simullanoousty implanted cnsscmssing 
stents (SIXS) woutd be sate. wotdd improve bemodynamcca and allow future 
as;ass to both pulmonary arteries, 
MethO0~: Twenty patients (15 M; 69 ~ 6.9 yo; 5.6 ~ 4.2 y post.as) with 
PBPPS, with (n .. 9) and witho~ MPA stenosis, had SIXS between 1993 
and 1997. The pnoclpal dmgnoses were dTGA (5), TOF (7), PA.VSD (41, 
Tmnctls (2) and AS/Ross procedure (1), We examined the change in RV:FA 
ratios, PA size and gradients, and branch sng!e wffh SIXS, 
RasfJffp: Hemodynamtca nd vessel size improved significantly with SIXS 
(table), but branch angles were not stgniftcantly changed, 
Rali~ Grad,'ents (P~nHg) Vessel size (ram] 
RVFA MPA-LPA MPA-RPA MPA LPA RPA 
Pre~tem 073:021 416~281 445":288 142±63 59-*20 67¢2.0 
Post-slant 039¢0.12 94_.71 99¢81 19;2¢38 133~2S 131z24 
Conclu~ons: SIXS provides excellem relief for pesloperatzve PBPPS 
white maintaining access tO both PAs and should be considered an excellent 
treatment choice for this problem. 
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~ Applicalion of Endovas©ular Stents on  the 
Management of Right Ventricular to Pulmonary 
Artery Conduit Stenosls 
C OvaerL CA. Catdarone. B.W. McCnndte, D. Nykanen. RM Freedom. 
LN. Benson. The Hospital for Stck Children, Unwersdy of Toronto, Toronto, 
Canada 
Background; Extracardiac conduits between the RV and pulmonary artenes 
commit patlents to multiple reoperations. Endovascular stenting of a stenot¢ 
conduit may delay reoporation. 
Methods; From 7/90 to 5/97. 42 patients underwent transcatheter stent 
insedion to relieve RV conduit stenosis Median age at procedure was 5.9 yrs 
(range, 6 me-17 yrs). with a median inten/al from conduit insertion of 24 ym 
(3 mo-13.9 yr'3). Clinical, echo, hemodynareic, ang~ographic and follow-up 
data were obtained. 
Results: RV systolic pressures decreased from 71 ± 18 mmHg to 48 ± 
15 mmHg (p = 0.0001) after slant placement, with an increase in the minimal 
diameter of the COnduit of 51 ± 44% (p = 0,0001), No major complications 
occurred. Eleven pts had 1 and 2 pts had 2 additional tronscathetar interven- 
tions to fudhcr dilate the slant or add an additional slant, Surgcal conduit 
replacement was required in 17 pts at a mean of 20 • 16 me after the slant 
placement. Of those without surgery, 12 pts have been followed <1 y. the 
remainder UP to 5.4 yrs with 1 late death at 2.8 yrs after stent placement. 
Freedom from surgical intervention was 62% at I yr, 66% at 2 yr and 39% 
at 3 yr after stenting There was no effect on freedom from surgery of pt age 
or duration of conduit at stenting, but higher initial RV pressures predicted 
decreased palliation, with a trend towards improved eady results in the 2nd 
half of the study. 
Conclusions: Transcatheter placement of endovsscular stents tn stenotic 
RV conduits significantly delays conduit replacement. 
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[-804--0"4~-4 Management of Pulmonary Artery Trauma due to 
L /  
Bal loon Dilation 
C.M. Baker, F.X. McGowan. JE  Lock, J.F. Kea=o. The Children's Hospital. 
Boston, Massachusetts, USA 
Background: Balloon dilation (BD) of the pulmonary artery (PA) is important m 
the management of peripheral pulmonary stenosis. Successful BD requires 
a controlled tear of the PA, however complications ranging from small pseu- 
doaneurysrns to PA rupture can occur. We report our expenence managing 
BD associated PA rupture. 
Methods: All records (1983-1997) for patients undergoing cardiac catheter- 
ization during which BD of a PA was performed were re,.-ewed using a corn- 
